Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
2,570 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00312442 | Phase II/III Study of WST09 in Prostate Cancer After Radiation Therapy | terminated | Phase 2 / Phase 3 | 16 | STEBA FranceINDUSTRY | 1 | Jun 2, 2010 | clinicaltrials |
| NCT00113516 | A Study Of SU011248 As Therapy In Patients With Locally Advanced Or Metastatic Non-Small Cell Lung Cancer | completed | Phase 2 | 84 | PfizerINDUSTRY | 3 | May 18, 2010 | clinicaltrials |
| NCT00101608 |
| Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium |
| completed |
| Phase 2 |
| 150 |
| Bristol-Myers SquibbINDUSTRY |
| 15 |
| Mar 2, 2010 |
| clinicaltrials |
| NCT00103831 | Oral Taxane in Combination With Pemetrexed (Alimta) in Patients With Recurrent Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | — | Bristol-Myers SquibbINDUSTRY | 2 | Mar 2, 2010 | clinicaltrials |
| NCT00261027 | Aromasin (Exemestane) in Patients With Recurrent or Refractory Stage II - IV Epithelial Ovarian Cancer | completed | Phase 2 | 30 | Ottawa Hospital Research InstituteOTHER | 1 | Mar 2, 2010 | clinicaltrials |
| NCT00289640 | Study of Ipilimumab (MDX-010) Monotherapy in Patients With Previously Treated Unresectable Stage III or IV Melanoma | completed | Phase 2 | 210 | Bristol-Myers SquibbINDUSTRY | 10 | Mar 2, 2010 | clinicaltrials |
| NCT00359450 | Study of BMS-275183 in Patients With Pretreated Locally Advanced or Metastatic NSCLC (Non Small Cell Lung Cancer) | terminated | Phase 2 | 186 | Bristol-Myers SquibbINDUSTRY | 8 | Mar 2, 2010 | clinicaltrials |
| NCT00038103 | Open-Label Study Of Exemestane With Or Without Celecoxib In Postmenopausal Women With ABC Having Progressed On Tamoxifen | completed | Phase 2 | 111 | PfizerINDUSTRY | 9 | Feb 25, 2010 | clinicaltrials |
| NCT00123864 | Study Using Intensity-modulated Radiation Therapy in Patients With Nasopharynx Cancer to Permit Sparing of Contralateral Parotid Gland Function | completed | Phase 1 / Phase 2 | 25 | Alberta Health servicesOTHER | 1 | Feb 9, 2010 | clinicaltrials |
| NCT00128999 | Study Using Induction Chemotherapy and Intensity-Modulated Radiation Therapy Guided by Combined CT and PET Imaging for Patients With Non-Small Cell Lung Cancer | completed | Phase 1 / Phase 2 | 5 | Alberta Health servicesOTHER | 1 | Feb 9, 2010 | clinicaltrials |
| NCT00316563 | Orexigenic Therapy With Delta-9-tetrahydrocannabinol in Advanced Cancer Patients With Chemosensory Abnormalities - a Pilot Study | completed | Phase 2 | 80 | Alberta Health servicesOTHER | 1 | Feb 9, 2010 | clinicaltrials |
| NCT00298987 | A Study of Dasatinib in Patients With Chronic Myelogenous Leukemia Who Are Resistant or Intolerant of Imatinib Mesylate | completed | Phase 2 | 400 | Bristol-Myers SquibbINDUSTRY | 2 | Feb 8, 2010 | clinicaltrials |
| NCT00239980 | Fragmin in Ovarian Cancer: Utility on Survival (FOCUS) | completed | Phase 2 | 77 | Ontario Clinical Oncology Group (OCOG)OTHER | 1 | Feb 3, 2010 | clinicaltrials |
| NCT00002937 | Paclitaxel With or Without PSC 833 in Treating Patients With Metastatic Breast Cancer | completed | Phase 2 | 70 | City of Hope Medical CenterOTHER | 2 | Jan 6, 2010 | clinicaltrials |
| NCT00730262 | Efficacy Study of TLN-4601 in Patients With Recurring Glioblastoma Multiforme | terminated | Phase 2 | 40 | Thallion PharmaceuticalsINDUSTRY | 2 | Dec 30, 2009 | clinicaltrials |
| NCT00988897 | Colorectal Cancer RECHALLENGE | withdrawn | Phase 2 | 0 | SanofiINDUSTRY | 1 | Dec 23, 2009 | clinicaltrials |
| NCT00363974 | Study of XIAP Antisense Given With Chemotherapy for Refractory/Relapsed AML | completed | Phase 1 / Phase 2 | 54 | Aegera TherapeuticsINDUSTRY | 2 | Dec 1, 2009 | clinicaltrials |
| NCT00002749 | Carboplatin in Patients With Progressive Gliomas | completed | Phase 2 | 25 | Duke UniversityOTHER | 2 | Oct 14, 2009 | clinicaltrials |
| NCT00042016 | Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Chronic Phase Who Are Refractory to Imatinib Mesylate (Gleevec) | completed | Phase 2 | 40 | Astex Pharmaceuticals, Inc.INDUSTRY | 2 | Oct 14, 2009 | clinicaltrials |
| NCT00474188 | A Study to Evaluate Lenalidomide Combined With Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma | terminated | Phase 2 | 26 | Celgene CorporationINDUSTRY | 3 | Sep 2, 2009 | clinicaltrials |
| NCT00152789 | Normal Prostate: Oxygenation of the Prostate Gland in Men Undergoing Prostate Biopsy | completed | Phase 2 | 40 | University Health Network, TorontoOTHER | 1 | Aug 10, 2009 | clinicaltrials |
| NCT00264498 | Phase II Iressa & Carbo/Gem in NSCLC | completed | Phase 2 | 38 | AstraZenecaINDUSTRY | 1 | Aug 3, 2009 | clinicaltrials |
| NCT00230386 | Role of Magnetic Resonance Imaging (MRI) Perfusion to Detect Disease in Prostate Carcinoma | completed | Phase 1 / Phase 2 | 50 | University Health Network, TorontoOTHER | 1 | Jul 14, 2009 | clinicaltrials |
| NCT00371553 | Phase-II Study of SU011248 (Sunitinib)in Male Patients With Relapsed or Cisplatin-Refractory Germ Cell Cancer | completed | Phase 2 | 33 | British Columbia Cancer AgencyOTHER | 1 | Jul 8, 2009 | clinicaltrials |
| NCT00044538 | Evaluation of BAY 59-8862 in Taxane Resistant Non-Small Cell Lung Cancer Patients | completed | Phase 2 | 102 | BayerINDUSTRY | 6 | Jun 22, 2009 | clinicaltrials |
| NCT00087958 | Intravenous RPR109881 in Male or Female Patients With Advanced Breast Cancer Who no Longer Respond to Anthracycline, Taxane and Capecitabine Treatment | completed | Phase 2 | 168 | SanofiINDUSTRY | 15 | May 1, 2009 | clinicaltrials |
| NCT00055146 | Study of ONTAK in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL) | completed | Phase 2 | 41 | Eisai Inc.INDUSTRY | 5 | Apr 17, 2009 | clinicaltrials |
| NCT00152841 | Effect of Iron and Vitamin E Supplementation on Disease Activity in Patients With Either Crohn's Disease or Ulcerative Colitis | terminated | Phase 2 | 30 | University Health Network, TorontoOTHER | 1 | Mar 17, 2009 | clinicaltrials |
| NCT00043576 | ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere | unknown | Phase 2 / Phase 3 | 250 | NovaceaINDUSTRY | 2 | Mar 12, 2009 | clinicaltrials |
| NCT00070629 | CPG 7909 Injection in Non-Small Cell Lung Cancer | completed | Phase 2 | 116 | PfizerINDUSTRY | 3 | Feb 10, 2009 | clinicaltrials |
| NCT00116610 | Picoplatin as Second-Line Therapy for Patients With Small Cell Lung Cancer | completed | Phase 2 | 75 | Poniard PharmaceuticalsINDUSTRY | 3 | Jan 21, 2009 | clinicaltrials |
| NCT00174863 | Evaluation of SR 31747A Versus Placebo in Androgen-Independent Non Metastatic Prostate Cancer(ODYSSEY) | completed | Phase 2 | 232 | SanofiINDUSTRY | 13 | Dec 23, 2008 | clinicaltrials |
| NCT00807196 | Zevalin With Non Myeloablative Allogeneic Stem Cell Transplantation in Patients With Non Hodgkin Lymphoma | unknown | Phase 1 / Phase 2 | 20 | Maisonneuve-Rosemont HospitalOTHER | 1 | Dec 11, 2008 | clinicaltrials |
| NCT00493857 | Study of Nimotuzumab and Irinotecan in Metastatic Colorectal Cancer | terminated | Phase 2 | 100 | YM BioSciencesINDUSTRY | 1 | Nov 17, 2008 | clinicaltrials |
| NCT00779896 | Tazarotene 0.1% Cream For the Treatment of Cutaneous T-Cell Lymphoma: A Prospective Study | unknown | Phase 1 / Phase 2 | 15 | McGill UniversityOTHER | 1 | Oct 24, 2008 | clinicaltrials |
| NCT00764972 | Phase IB/II Trial Combining Vinorelbine With Sorafenib as First-Line Treatment in Patients With Metastatic Breast Cancer | unknown | Phase 1 / Phase 2 | 36 | McGill UniversityOTHER | 1 | Oct 21, 2008 | clinicaltrials |
| NCT00129844 | Study of Motexafin Gadolinium (MGd) for Second Line Treatment of Non-Small-Cell Lung Cancer | completed | Phase 2 | 108 | Pharmacyclics LLC.INDUSTRY | 2 | Aug 20, 2008 | clinicaltrials |
| NCT00005880 | Budesonide in Treating Former and Current Smokers With Bronchial Dysplasia | completed | Phase 2 | — | British Columbia Cancer AgencyOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00039156 | BAY 59-8862 in Treating Patients With Refractory Non-Hodgkin's Lymphoma | unknown | Phase 2 | — | TheradexINDUSTRY | 2 | Jul 24, 2008 | clinicaltrials |
| NCT00039169 | BAY 59-8862 in Treating Patients With Advanced Kidney Cancer | unknown | Phase 2 | — | TheradexINDUSTRY | 2 | Jul 24, 2008 | clinicaltrials |
| NCT00187031 | A Phase II Study of Topotecan in Children With Recurrent Wilms Tumor | completed | Phase 2 | 37 | St. Jude Children's Research HospitalOTHER | 2 | Jun 4, 2008 | clinicaltrials |
| NCT00601016 | A Phase II Study of Imiquimod 5 % Cream for the Treatment of Hemangioma in Infancy | completed | Phase 2 | 18 | St. Justine's HospitalOTHER | 1 | Jan 25, 2008 | clinicaltrials |
| NCT00072930 | MEDI-522 in the Treatment of Patients With Metastatic Androgen-Independent Prostate Cancer | completed | Phase 2 | 150 | MedImmune LLCINDUSTRY | 7 | Jan 15, 2008 | clinicaltrials |
| NCT00069875 | A Study With Gemcitabine, Cisplatin, and LY293111 in Non-Small Cell Lung Cancer | completed | Phase 2 | 195 | Eli Lilly and CompanyINDUSTRY | 6 | Dec 21, 2007 | clinicaltrials |
| NCT00034372 | Multicenter Clinical Trial of Intravenous OvaRex MAb-B43.13 as Post-Chemotherapy Consolidation for Ovarian Carcinoma | terminated | Phase 2 | 102 | Unither PharmaceuticalsINDUSTRY | 2 | Dec 18, 2007 | clinicaltrials |
| NCT00041990 | Phase II Trial of Decitabine in Patients With Chronic Myelogenous Leukemia Accelerated Phase Who Are Refractory to Imatinib Mesylate (Gleevec) | completed | Phase 2 | 40 | Astex Pharmaceuticals, Inc.INDUSTRY | 2 | Dec 17, 2007 | clinicaltrials |
| NCT00073112 | A Study of ABT-751 in Patients With Renal Cell Cancer | completed | Phase 2 | 60 | AbbottINDUSTRY | 2 | Nov 29, 2007 | clinicaltrials |
| NCT00127478 | A Long Term Safety Study With Atrasentan | completed | Phase 2 / Phase 3 | 166 | AbbottINDUSTRY | 5 | Nov 29, 2007 | clinicaltrials |
| NCT00562471 | Safety and Efficacy Study of a Hydrogel, Applied Following Removal of Myomas During Gynecologic Surgery, Administered for the Prevention/Reduction of Postoperative Adhesion Formation | completed | Phase 1 / Phase 2 | 76 | Angiotech PharmaceuticalsINDUSTRY | 3 | Nov 22, 2007 | clinicaltrials |
| NCT00259675 | Alternating Cycles of Carboplatin/Gemcitabine and Carboplatin/Taxol for Advanced Stage NSCLC | completed | Phase 2 | 100 | University of SaskatchewanOTHER | 1 | Nov 15, 2007 | clinicaltrials |
Data updated 22 days agoSource updated unknownsource: clinicaltrials